Evidence map›Paper›PMID 32454771›Full record

ArticleTurkish journal of pharmaceutical sciences2020

Various

Asmaa Nabil-Adam, Mohamed A Shreadah, Nehad M Abd El Moneam, Samy A El-Assar

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of pharmaceutical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Asmaa Nabil-AdamMarine Biotechnology and Natural Products Lab (MBNP), National Institute of Oceanography and Fisheries (NIOF), Alexandria, Egypt.ORCID https://orcid.org/0000-0002-5560-0674
Mohamed A ShreadahMarine Biotechnology and Natural Products Lab (MBNP), National Institute of Oceanography and Fisheries (NIOF), Alexandria, Egypt.
Nehad M Abd El MoneamAlexandria University, Faculty of Science, Department of Biochemistry, Alexandria, Egypt.
Samy A El-AssarAlexandria University, Faculty of Science, Department of Botany and Microbiology, Alexandria, Egypt.
Alexandria University · EGNational Institute of Oceanography and Fisheries · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe present study revealed the presence of bioactive constituents in MATERIALS AND

methodsCytotoxicity was tested against hepatocellular carcinoma cell lines as a prescreening test.

resultsThe HES extract had high contents of total phenolic compounds (0.061 mg/g), flavonoids (0.2839 mg/g), and carotenoids (1.976 mg/g). Moreover, the HES extract showed high antioxidant capacity with 93.0% and 99% at 1 mg using 2.2'-Diphenyl-α-picrylhydrazyl and 2.2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid), respectively. Cytotoxic activity against cancerous cell lines showed that the HES extract could inhibit cell growth effectively with IC

conclusionThis marine sponge isolated from the Red Sea showed tremendous activity against many diseases and it is considered an excellent source for bioactive pharmaceutical compounds.

Indexed as

anti-Alzheimeranticanceranti-inflammatoryantioxidantantiviralcytotoxicRed Sea

Identifiers

PMID32454771
PMCPMC7227922
OpenAlexW3018252765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.